Diagnos Inc. DGNOF
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.50% | -0.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.50% | -0.91% | |||
| Cost of Revenue | -375.10% | 9.72% | |||
| Gross Profit | 389.49% | -10.16% | |||
| SG&A Expenses | 19.97% | 1.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.28% | 4.28% | |||
| Operating Income | -8.33% | -4.35% | |||
| Income Before Tax | -3.66% | -4.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.66% | -4.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.66% | -4.64% | |||
| EBIT | -8.33% | -4.35% | |||
| EBITDA | -8.41% | -7.63% | |||
| EPS Basic | -11.27% | 8.97% | |||
| Normalized Basic EPS | -11.36% | 10.20% | |||
| EPS Diluted | -11.27% | 8.97% | |||
| Normalized Diluted EPS | -11.36% | 10.20% | |||
| Average Basic Shares Outstanding | -6.99% | 14.81% | |||
| Average Diluted Shares Outstanding | -6.99% | 14.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||